decorative image
Official websites use .gov
A .gov website belongs to an official government organization in the United States.
decorative image
Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

n/a Warning! This browser is not supported - Some features might not work. Try using a different browser such as Chrome, Edge, Firefox, or Safari.

Weekly NIH Funding Opportunities and Notices
April 28, 2017

General Notices

Funding Opportunities

  • Promoting NICHD Areas of Research for HIV/AIDS in Maternal and Child Health (R01)
    (PA-17-262)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): Standard AIDS dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on .
  • Innovation for HIV Vaccine Discovery (R01)
    (PAR-17-263)
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): August 1, 2017; August 1, 2018; August 1, 2019, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on these dates.
  • Innovative Mental Health Services Research Not Involving Clinical Trials (R01)
    (PAR-17-264)
    National Institute of Mental Health
    Application Receipt Date(s): Standard dates apply , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Paul B. Beeson Emerging Leaders Career Development Award in Aging (K76)
    (RFA-AG-18-006)
    National Institute on Aging
    Application Receipt Date(s): October 19, 2017), by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Coordinating Center for Claude D. Pepper Older Americans Independence Centers (U24)
    (RFA-AG-18-008)
    National Institute on Aging
    Application Receipt Date(s): October 19, 2017, by 5:00 PM local time of applicant organization. All types of applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Novel Cell Non-autonomous Mechanisms of Aging (R01)
    (RFA-AG-18-009)
    National Institute on Aging
    Application Receipt Date(s): October 3, 2017 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Nasal Delivery of CNS Therapeutics (R43/R44)
    (RFA-DA-18-006)
    National Institute on Drug Abuse
    Application Receipt Date(s): August 23, 2017, by 5:00 PM local time of applicant organization.
  • Nasal Delivery of CNS Therapeutics (R41/R42)
    (RFA-DA-18-007)
    National Institute on Drug Abuse
    Application Receipt Date(s): August 23, 2017, by 5:00 PM local time of applicant organization.
  • Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
    (RFA-DK-17-508)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): July 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R43/R44)
    (RFA-HL-17-023)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R41/R42)
    (RFA-HL-17-024)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U54)
    (RFA-HL-17-025)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM1)
    (RFA-HL-17-026)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UC4)
    (RFA-HL-17-027)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U24)
    (RFA-HL-17-028)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R01)
    (RFA-HL-17-029)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (R24)
    (RFA-HL-17-030)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (UM2)
    (RFA-HL-17-031)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P50)
    (RFA-HL-17-032)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (P41)
    (RFA-HL-17-033)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Revision Applications for Regenerative Medicine Innovation Projects (RMIP) (U01)
    (RFA-HL-17-034)
    National Heart, Lung, and Blood Institute
    National Institute on Aging
    National Institute of Allergy and Infectious Diseases
    National Institute of Arthritis and Musculoskeletal and Skin Diseases
    National Institute on Deafness and Other Communication Disorders
    National Institute of Dental and Craniofacial Research
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Eye Institute
    National Institute of Mental Health
    National Institute of Neurological Disorders and Stroke
    National Center for Advancing Translational Sciences
    National Institute of Biomedical Imaging and Bioengineering
    National Center for Advancing Translational Sciences
    Application Receipt Date(s): June 26, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Translational Outcomes Project in Neurotrauma (TOP-NT) (UG3/UH3)
    (RFA-NS-17-023)
    National Institute of Neurological Disorders and Stroke
    Application Receipt Date(s): August 21, 2017), by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late Applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.